Trilogy Metals Inc (AMEX:TMQ) does about 1.53M shares in volume on a normal day but saw 4495983 shares change hands in the recent trading day. The company now has a market cap of 387.02M USD. Its current market price is $1.28, marking an increase of 36.66% compared to the previous close of $0.94. The 52 week high reached by this stock is $1.29 whilst the lowest price level in 52 weeks is $0.25.
Trilogy Metals Inc (TMQ) has a 20-day trading average at $0.7923 and the current price is -0.78% off the 52-week high compared with 411.80% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.6192 and its 200-day simple moving average is $0.5303. If we look at the stock’s price movements over the week, volatility stands at 17.47%, which decreases to 14.14% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 80.15 to suggest the stock is overbought.
The consensus objective for the share price is $1.02, suggesting that the stock has a potential downside of -25.49% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 2 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Moderate Buy the stock.
The current price level is 61.56%, 106.71%, and 141.38% away from its SMA20, SMA50, and SMA200 respectively, with the TMQ price moving below the 50-day SMA on current market day. Trilogy Metals Inc (TMQ) stock is up 26.73% over the week and 125.35% over the past month. Its price is 197.67% year-to-date and 184.51% over the past year.
The stock last released its quarterly earnings report for quarter ended 8/31/2024, with the company’s earnings per share (EPS) of -0.03 below consensus estimates by -0.01. The company’s next earnings report forecasts estimating quarterly EPS at -0.01 and -0.08 for whole year.
To reach the target analysts have set, the stock logically needs to shrink -25.49 percent from here.
The company has a return on investment of -7.45% and return on equity of -7.29%. The beta has a value of 1.43. Price to book ratio is 1.54.